Literature DB >> 21674243

The oncofetal gene survivin promotes cell proliferation and survival in primary human osteoblastic cells.

Philipp Lechler1, Jens Schaumburger, Franz X Köck, Sanjeevi Balakrishnan, Stavros Doukas, Lukas Prantl, Joachim Grifka.   

Abstract

Survivin, the smallest member of the inhibitor of apoptosis gene family, is critical for the regulation of mitosis and maintenance of cell viability during embryonic development and cancer, while not being detectable in most adult differentiated tissues. We know little about whether survivin plays any physiological or pathophysiological role in the adult musculoskeletal system. We studied the expression of survivin in primary human osteoblastic cells and its biological functions in vitro. Survivin was detected by immunoblotting and real-time PCR. Subcellular localization was analyzed by immunofluorescence. Transfection of siRNA and plasmids coding for wild-type survivin was performed to study survivin function, i.e., proliferation and apoptosis assays. Survivin mRNA and protein are expressed in primary human osteoblastic cells. During interphase survivin localizes predominantly to the cytoplasmic compartment, which is relevant for the organization of the spindle apparatus during mitosis. Survivin knockdown resulted in an arrest of the cell cycle at the G(2)/M phase and increased rates of apoptosis. Elevated levels of survivin in primary human osteoblasts enhanced proliferation and cell viability. Taken together, we demonstrate for the first time that survivin is expressed in primary human osteoblastic cells on the mRNA and protein levels. Our results indicate that survivin is a critical factor for cell division and cell viability in primary human osteoblastic cells. Learning more about survivin's role in human osteoblasts could be an important step toward understanding the complex processes involved in bone homeostasis and remodeling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21674243     DOI: 10.1007/s00223-011-9508-y

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  5 in total

1.  [The oncofetal gene survivin - a possible target gene for regenerative therapy concepts in cartilaginous tissue].

Authors:  P Lechler; M Handel; S Anders; S Balakrishnan; J Grifka
Journal:  Orthopade       Date:  2012-04       Impact factor: 1.087

2.  Identification of GRP78 as a molecular target of medicarpin in osteoblast cells by proteomics.

Authors:  Jyoti Kureel; Aijaz A John; Ashutosh Raghuvanshi; Pallavi Awasthi; Atul Goel; Divya Singh
Journal:  Mol Cell Biochem       Date:  2016-06-17       Impact factor: 3.396

3.  SURVIVIN POSITIVITY AND PROGNOSTIC FACTORS IN PAPILLARY THYROID CARCINOMAS.

Authors:  E Usturali Keskin; E Taştekin; N Can; A N Mut; M Celik; B Yilmaz Bulbul; F Oz Puyan; F Ozyilmaz; S Guldiken; S Ayturk; A Sezer; F Üstün
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Oct-Dec       Impact factor: 1.104

4.  Cissus quadrangularis inhibits IL-1β induced inflammatory responses on chondrocytes and alleviates bone deterioration in osteotomized rats via p38 MAPK signaling.

Authors:  Jagat R Kanwar; Rasika M Samarasinghe; Kuldeep Kumar; Ramesh Arya; Sanjeev Sharma; Shu-Feng Zhou; Sreenivasan Sasidharan; Rupinder K Kanwar
Journal:  Drug Des Devel Ther       Date:  2015-06-05       Impact factor: 4.162

5.  miR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation.

Authors:  J Kureel; M Dixit; A M Tyagi; M N Mansoori; K Srivastava; A Raghuvanshi; R Maurya; R Trivedi; A Goel; D Singh
Journal:  Cell Death Dis       Date:  2014-02-06       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.